• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两医院新冠感染后继发毛霉菌病的病例系列研究。

A case series of mucormycosis after covid infection in two hospitals.

机构信息

Post Graduation Program in Dentistry, Universidade Federal da Paraíba (UFPB), Campus I - Cidade Universitária, João Pessoa, Paraíba 58033-455, Brazil.

Universidad Autónoma de Nuevo León, Mexico.

出版信息

J Stomatol Oral Maxillofac Surg. 2022 Nov;123(6):e757-e759. doi: 10.1016/j.jormas.2022.06.003. Epub 2022 Jun 11.

DOI:10.1016/j.jormas.2022.06.003
PMID:35700951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9188452/
Abstract

This paper aims to discuss clinical aspects of mucormycosis. This case series was conducted in two services, comprising six mucormycosis cases during COVID-19 pandemic. About gender, there are 4 (66.7%) males and 2 (33.3%) females with mean age (48.7 ± 9.4) years. All cases presented complaints of pain and swelling in oral cavity and had an aggressive clinical presentation. Five patients had diabetes and one had a nasal non-Hodgkin lymphoma. Histologically, large, branched, hyphae associated with necrotic areas were observed, confirming microscopically such as mucormycosis through PAS and GMS stains. In four cases, treatment consisted in surgical debridement associated with antifungal therapy. All patients were submitted to debridement and received antifungal treatment (amphotericin B). Five patients were followed up without clinical recurrence, but unfortunately one patient died. Diagnosis of mucormycosis should be early because it is related to high mortality. The treatment consists of surgical debridement associated with antifungal therapy.

摘要

本文旨在讨论毛霉病的临床方面。本病例系列研究在两个科室进行,共纳入 COVID-19 大流行期间的 6 例毛霉病病例。关于性别,有 4 例(66.7%)男性和 2 例(33.3%)女性,平均年龄(48.7±9.4)岁。所有病例均表现出口腔疼痛和肿胀,并呈侵袭性临床表现。5 例患者患有糖尿病,1 例患有鼻非霍奇金淋巴瘤。组织学上,观察到与坏死区相关的大型、分支状菌丝,通过 PAS 和 GMS 染色微观上证实为毛霉病。4 例患者接受了手术清创术联合抗真菌治疗。所有患者均接受清创术和抗真菌治疗(两性霉素 B)。5 例患者无临床复发,随访,但不幸的是,1 例患者死亡。毛霉病的诊断应尽早进行,因为它与高死亡率有关。治疗包括手术清创术联合抗真菌治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/889c/9188452/535d6feb2758/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/889c/9188452/356dfbdaeba6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/889c/9188452/535d6feb2758/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/889c/9188452/356dfbdaeba6/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/889c/9188452/535d6feb2758/gr2_lrg.jpg

相似文献

1
A case series of mucormycosis after covid infection in two hospitals.两医院新冠感染后继发毛霉菌病的病例系列研究。
J Stomatol Oral Maxillofac Surg. 2022 Nov;123(6):e757-e759. doi: 10.1016/j.jormas.2022.06.003. Epub 2022 Jun 11.
2
Reducing mortality in mucormycosis of the head and neck in diabetic patients: A CARE case series.降低糖尿病患者头颈部毛霉菌病的死亡率:一项CARE病例系列研究
Eur Ann Otorhinolaryngol Head Neck Dis. 2022 May;139(3):146-152. doi: 10.1016/j.anorl.2021.06.015. Epub 2021 Sep 3.
3
Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.印度北部一家三级护理中心 COVID-19 相关的鼻眶脑毛霉菌病患者分析。
Indian J Ophthalmol. 2022 Jun;70(6):2163-2168. doi: 10.4103/ijo.IJO_340_22.
4
Mucormycosis: a community hospital perspective.毛霉菌病:社区医院视角
Ala Med. 1990 Jul-Aug;60(1-2):38, 40-1.
5
Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature.COVID-19 患者中毛霉病(接合菌病)日益引起关注;基于文献病例报告的分析和综述。
Acta Biomed. 2021 Sep 2;92(4):e2021271. doi: 10.23750/abm.v92i4.11787.
6
Mucormycosis: four case reports.毛霉菌病:4例病例报告
Tunis Med. 2008 Feb;86(2):165-8.
7
Rise of the phoenix: Mucormycosis in COVID-19 times.凤凰涅槃:新冠时期的毛霉菌病。
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. doi: 10.4103/ijo.IJO_310_21.
8
Rhino-orbito-cerebral mucormycosis: five cases.鼻-眶-脑毛霉病:五例报告。
Med Mal Infect. 2012 Dec;42(12):591-8. doi: 10.1016/j.medmal.2012.10.001. Epub 2012 Oct 30.
9
Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report.糖尿病酮症酸中毒与 2019 冠状病毒病相关毛霉菌病:病例报告。
J Med Case Rep. 2022 Oct 31;16(1):400. doi: 10.1186/s13256-022-03594-2.
10
Rhinocerebral mucormycosis in Taiwan.台湾的鼻脑型毛霉菌病
J Microbiol Immunol Infect. 2003 Dec;36(4):266-9.

引用本文的文献

1
Unravelling the Complexity of Mucormycosis-A Rare Case Report.解析毛霉病的复杂性——一例罕见病例报告
Ann Maxillofac Surg. 2024 Jan-Jun;14(1):96-98. doi: 10.4103/ams.ams_204_23. Epub 2024 Jul 19.
2
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.新型冠状病毒肺炎相关毛霉菌病(CAM)的临床表型:一项综述
Diagnostics (Basel). 2022 Dec 8;12(12):3092. doi: 10.3390/diagnostics12123092.
3
Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.新型冠状病毒肺炎相关毛霉菌病和曲霉病的比较风险评估:一项系统评价

本文引用的文献

1
Post-COVID mucormycosis: Ascertainment of the pathological diagnostic approach.新冠后毛霉菌病:病理诊断方法的确定
J Oral Maxillofac Pathol. 2021 May-Aug;25(2):219-222. doi: 10.4103/0973-029X.325117. Epub 2021 Aug 31.
2
Post-COVID fungal infections of maxillofacial region: a systematic review.头颈部 COVID-19 后真菌性感染:系统性综述。
Oral Maxillofac Surg. 2022 Sep;26(3):357-363. doi: 10.1007/s10006-021-01010-5. Epub 2021 Oct 7.
3
Mycotic infections - mucormycosis and oral candidiasis associated with Covid-19: a significant and challenging association.
Health Sci Rep. 2022 Aug 18;5(5):e789. doi: 10.1002/hsr2.789. eCollection 2022 Sep.
霉菌感染——毛霉病和与新冠病毒相关的口腔念珠菌病:一种重要且具有挑战性的关联。
J Oral Microbiol. 2021 Aug 26;13(1):1967699. doi: 10.1080/20002297.2021.1967699. eCollection 2021.
4
Oral mucormycosis in post-COVID-19 patients: A case series.新冠病毒感染康复后患者的口腔毛霉菌病:病例系列
Oral Dis. 2022 Nov;28 Suppl 2:2591-2592. doi: 10.1111/odi.13973. Epub 2021 Aug 20.
5
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?新冠病毒感染患者中毛霉菌病发病率上升:在第二波疫情期间,这对印度来说是另一个挑战?
Lancet Respir Med. 2021 Aug;9(8):e77. doi: 10.1016/S2213-2600(21)00265-4. Epub 2021 Jun 3.
6
COVID-19 and Mucormycosis of the Craniofacial skeleton: Causal, Contributory or Coincidental?新型冠状病毒肺炎与颅面骨骼毛霉菌病:因果关系、促成因素还是巧合?
J Maxillofac Oral Surg. 2021 Jun;20(2):165-166. doi: 10.1007/s12663-021-01547-8. Epub 2021 Mar 27.
7
Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection.病毒感染与口腔病变的关联:严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的作用
Front Med (Lausanne). 2021 Jan 14;7:571214. doi: 10.3389/fmed.2020.571214. eCollection 2020.
8
Oral Manifestations in Patients with COVID-19: A Living Systematic Review.《COVID-19 患者的口腔表现:一项实时系统综述》。
J Dent Res. 2021 Feb;100(2):141-154. doi: 10.1177/0022034520957289. Epub 2020 Sep 11.
9
Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?COVID-19 患者的口腔黏膜病变:新的症状还是继发表现?
Int J Infect Dis. 2020 Aug;97:326-328. doi: 10.1016/j.ijid.2020.06.012. Epub 2020 Jun 9.
10
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南:欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.